Cogent Biosciences - Senior Director, Global Market Access

• Global Market Access & Value Strategy • Develop and execute global market access strategies for oncology pipeline and commercial products across the product lifecycle. • Identify market access opportunities, risks, and potential barriers across the US and priority international markets. • Develop market-specific strategies informed by payer dynamics, reimbursement and HTA requirements, clinical practice, treatment pathways, and competitive landscapes. • Integrate market access, pricing, reimbursement, HEOR, and value considerations into broader product, development, and commercialization strategies. • Monitor changes in oncology treatment, reimbursement, and health-system environments and assess implications for the portfolio. • Evidence, HEOR & Oncology Value Strategy • Lead the integration of market access and HEOR perspectives into the overall value strategy for oncology assets. • Translate the clinical profile, unmet need, and treatment landscape into differentiated payer and HTA value propositions. • Partner closely with HEOR and Medical Affairs to define evidence requirements and develop evidence-generation strategies across key markets. • Provide market access input into clinical development plans, endpoints, comparators, patient populations, and evidence-generation priorities. • Identify evidence gaps that may create future access barriers and work with HEOR and cross-functional teams to address them. • Guide development of value dossiers, economic models, budget impact analyses, and other market access tools in partnership with HEOR. • Ensure HEOR outputs are effectively translated into payer, HTA, and broader market access strategies. • Pricing & Reimbursement • Develop and support global pricing and reimbursement strategies in partnership with the VP, Value & Access Strategy and cross-functional stakeholders. • Conduct pricing and reimbursement assessments across priority markets, considering clinical value, treatment alternatives, healthcare-system dynamics, and market access requirements. • Develop pricing scenarios and assumptions to support business planning, forecasting, and strategic decision-making. • Ensure pricing considerations are appropriately integrated with the overall value and access strategy throughout the product lifecycle. • Launch Readiness • Serve as a core market access leader within cross-functional launch teams. • Develop market access launch plans, milestones, risks, and mitigation strategies. • Incorporate payer, reimbursement, pricing, HTA, and evidence considerations into launch sequencing and commercialization planning. • Support development of payer-facing materials and value communication tools. • Help establish appropriate access metrics and readiness assessments. • Ensure the organization is prepared to address market access considerations in key launch markets. • Bachelor’s degree in a relevant discipline; advanced degree preferred (e.g., MBA, MPH, PharmD, MS). • 10+ years of experience in pharmaceutical or biotechnology market access, pricing, reimbursement, HEOR, or a related discipline. • Demonstrated experience developing market access strategies in the US and international markets. • Experience in oncology, specialty pharmaceuticals, or other complex therapeutic areas. • Experience supporting products through development and/or commercialization, ideally including a launch. • Experience translating clinical evidence and product value into payer and HTA strategies. • Understanding of global pricing, reimbursement, and HTA environments. • Strong analytical, strategic planning, project management, and communication skills.